Our key services
Perivia is dedicated to providing high-quality end-to-end competitive intelligence and strategy support, leveraging our common sense approach and expertise across the full drug lifecycle.
Â
Each potential client engagement starts with a call to understand three key things: 1) the client's needs, 2) any existing pain points, and 3) a wish list of deliverables or services.Â
​
Thought partnership
Competitive intelligence
Maintain a keen understanding of the client's position and maintain expert understanding of a given therapy area and general pharma dynamics to ensure deliverables always include the "so what".
Monitoring and analysis of competitor activity via secondary sources as well as primary CI developed through desk-based interviews and at international medical congresses.
Strategy workshops
Medical congress coverage
End-to-end support for strategy, medical, and war game workshops, from exercise brainstorming and pre-read development to in-person or virtual moderation and post-workshop deliverables. Every workshop is focused, output-driven, and designed to maximise stakeholder engagement.
Visual and impactful deliverables, highlighting the key data and trends for our clients, including what it means, as well as on-the-ground tenacious primary intelligence gathering.
Industry trend analysis
Opportunity assessments
Analysis of therapeutic area shifts, regulatory changes, and pricing and access dynamics, including the impact of US most favored nation (MFN) pricing, European HTA reform, and generic and biosimilar entry.
Rigorous evaluation of potential assets, business development opportunities, and market entry strategies to support portfolio-level decision-making.Â
Competitor threat assessments and standard of care evolution
Evaluation of how pipeline and newly launched competitors could reshape the treatment paradigm, and what that means for the client’s asset and positioning.
Commercial strategy and launch readiness
Support from pre-launch planning through to market entry, including assessment of competitor commercial models using publicly available information: field force size, structure and deployment, HCP engagement, and patient support programs.